Evidence map›Paper›PMID 25832897›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2015

Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients.

Sebastiano Mercadante, Federica Aielli, Claudio Adile, Patrizia Ferrera, Alessandro Valle, Flavio Fusco, Amanda Caruselli, Claudio Cartoni, Pizzuto Massimo, Francesco Masedu and 2 more

2 registry-linked trialsAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 53 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 8 pooled it
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04911335 phase2completednot on this mapstarted 2021, after this paper: background citation

Sicurezza ed Efficacia di un Prodotto a Base di Propoli (FARINGEL PLUS) Nella Prevenzione e Nel Trattamento Della Mucosite Orale in Pazienti in Cure Palliative: Uno Studio di Fase 2

TypeinterventionalSponsorCampus Bio-Medico UniversityRan2021 to 2022Enrolled77ConditionsOral MucositisArmsFaringel plus and oral hygiene
NCT06465628 narecruitingnot on this mapstarted 2024, after this paper: background citation

Effect of Self-administered Acupressure for Improving Xerostomia in Head and Neck Cancer Patients: a Randomized Controlled Trial

TypeinterventionalSponsorThe University of Hong KongRan2024 to 2027Enrolled126ConditionsHead and Neck Cancer, XerostomiaArmsSelf-administered acupressure, Oral health education
3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 8 syntheses or guidelines pooled it, 162 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Prevalence of oral diseases in patients under palliative care: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Azithromycin oral suspension in prevention and management of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized controlled trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Trial
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Barrier-forming lipid solution for severe oral mucositis: effect on oral intake interruption in head and neck cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Sebastiano MercadantePain Relief and Supportive Care Unit, La Maddalena Cancer Center, Palermo, Italy. terapiadeldolore@lamaddalenanet.it.
Federica AielliDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. federica.aielli@univaq.it.
Claudio AdilePain Relief and Supportive Care Unit, La Maddalena Cancer Center, Palermo, Italy. claudio.adile@hotmail.it.
Patrizia FerreraPain Relief and Supportive Care Unit, La Maddalena Cancer Center, Palermo, Italy. patriziaferrera@inwind.it.
Alessandro ValleFaro Foundation, Turin, Palermo, Italy. Alessandro.valle@tin.it.
Flavio FuscoHome Care Program, Asp 6, Genoa, Italy. Flavio.Fusco@asl3.liguria.it.
Amanda CaruselliPain Relief and Supportive Care Unit, La Maddalena Cancer Center, Palermo, Italy. amandacaruselli@virgilio.it.
Claudio CartoniDivision of Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto I, Home Care Service of the Rome Section of the Italian Association Against Leukemias (RomAIL), Rome, Italy. cartoni@bce.uniroma1.it.
Pizzuto MassimoPalliative Care Unit, Istituti Clinici di Perfezionamento Hospital, Milan, Italy. massimo.pizzuto@icp.mi.it.
Francesco MaseduDepartment of Biotechnological and Applied Clinical Sciences, Section of Clinical Epidemiology and Environmental Medicine, University of L'Aquila, L'Aquila, Italy. francesco.masedu@cc.univaq.it.
Marco ValentiDepartment of Biotechnological and Applied Clinical Sciences, Section of Clinical Epidemiology and Environmental Medicine, University of L'Aquila, L'Aquila, Italy. marco.valenti@cc.univaq.it.
Giampiero PorzioDepartment of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy. porzio@sctf.it.
University of L'Aquila · ITLa Maddalena · ITIstituti Clinici di Perfezionamento · ITPoliclinico Umberto I · ITSocietà per l’Assistenza al Malato Oncologico Terminale · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOral symptoms can be a sign of an underlying systemic condition and have a significant impact on quality of life, nutrition, and cost of care, while these lesions are often studied in the context of cancer treatment. However, information regarding oral symptoms in advanced cancer patients is poor. The aim of this multicenter study was to determine the prevalence and the characteristics of oral symptoms in a large population of advanced cancer patients.

methodsA consecutive sample of patients with advanced cancer for a period of 6 months was prospectively assessed for an observational study. At time of admission, the epidemiological characteristics, surgery-radiotherapy of head and neck, and oncologic treatments in the last month were recorded. The presence of mucositis, dry mouth, and dysphagia was assessed by clinical examination and patients' report and their intensity recorded. Patients were also asked whether they had limitation on nutrition of hydration due to the local condition.

resultsSix hundred sixty-nine patients were surveyed in the period taken into consideration. The mean age was 72.1 years (SD 12.3), and 342 patients were males. The primary tumors are listed in Table 1. The prevalence of mucositis was 22.3 %. The symptom relevantly reduced the ingestion of food or fluids and was statistically associated with the Karnofsky level and head and neck cancer. The prevalence of dry mouth was 40.4 %, with a mean intensity of 5.4 (SD 2.1). Several drugs were concomitantly given, particularly opioids (78 %), corticosteroids (75.3 %), and diuretics (70.2 %). Various and nonhomogeneous treatments were given for dry mouth, that was statistically associated with current or recent chemotherapy, and hematological tumors. The prevalence of dysphagia was 15.4 % with a mean intensity of 5.34 (SD 3). Dysphagia for liquids was observed in 52.4 % of cases. A high level of limitation for oral nutrition due to dysphagia was found, and in 53.4 % of patients, alternative routes to the oral one were used. Dysphagia was statistically associated with the Karnofsky level and head and neck cancer. A strong relationship between the three oral symptoms was found.

conclusionIn advanced cancer patients, a range of oral problems significantly may impact on the physical, social, and psychological well-being of advanced cancer patients to varying degrees. These symptoms should be carefully assessed early but become imperative in the palliative care setting when they produce relevant consequences that may be life-threatening other than limiting the daily activities, particularly eating and drinking.

Indexed as

AdultAgedAged, 80 and overDeglutition DisordersFemaleHumansKarnofsky Performance StatusMaleMiddle AgedMucositisNeoplasmsPalliative CarePrevalenceQuality of LifeStomatitisXerostomiaAdvanced cancerDry mouthDysphagiaMucositisOral symptomsPalliative careSupportive care

Identifiers

PMID25832897
OpenAlexW2014828795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.